Shine-On BioMedical Co (ROCO:6926) Long-Term Debt: NT$0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6926 Shine-On BioMedical Co Ltd ROCO:6926
13 GF Score
Price NT$63.00
View Full Analysis

What is Shine-On BioMedical Co Long-Term Debt?

Shine-On BioMedical Co ROCO:6926 +0.16% 13 Long-Term Debt is NT$0.00 Mil as of Dec. 2025. GuruFocus rates ROCO:6926 with a GF Score™ of 13/100.

Shine-On BioMedical Co's Long-Term Debt for the quarter that ended in Dec. 2025 was NT$0.00 Mil.

Shine-On BioMedical Co  (ROCO:6926) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Shine-On BioMedical Co Long-Term Debt Related Terms

Shine-On BioMedical Co Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Shine-On BioMedical Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shine-On BioMedical Co Long-Term Debt Chart

Shine-On BioMedical Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Shine-On BioMedical Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:6926
13GF Score
Shine-On BioMedical Co Ltd ROCO:6926
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of NT$0.00 Mil mean?
Shine-On BioMedical Co (ROCO:6926) has a Long-Term Debt of NT$0.00 Mil as of Dec. 2025.
Is Shine-On BioMedical Co's Long-Term Debt too high?
Shine-On BioMedical Co's current Long-Term Debt is NT$0.00 Mil. Overall, Shine-On BioMedical Co has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Shine-On BioMedical Co's Long-Term Debt compare to VRTX and REGN?
Shine-On BioMedical Co's Long-Term Debt of NT$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Biotechnology company?
A good Long-Term Debt depends on the Biotechnology industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Shine-On BioMedical Co's current Long-Term Debt is NT$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shine-On BioMedical Co stock overvalued right now?
Shine-On BioMedical Co (ROCO:6926) has a current Long-Term Debt of NT$0.00 Mil. The current Long-Term Debt is NT$0.00 Mil. Shine-On BioMedical Co's overall GF Score™ is 13/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Shine-On BioMedical Co (ROCO:6926), the current Long-Term Debt is NT$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shine-On BioMedical Co Business Description

Address No. 573, Taiwan Boulevard, 10th Floor, Section 2, West District, Taichung, TWN
Shine-On BioMedical Co Ltd develops drugs based on antibodies and nucleic acids. The Company researches, develops, manufactures, and distributes antibody anticancer drugs, nucleic acid anticancer drugs. The company's drug development and nucleic acid therapeutics are focused on providing patients with effective cancer treatment options.
13GF Score

Get the complete analysis for ROCO:6926

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$63.00
Price